Live from the NIH registry
Studies recruiting near Corona right now
Top 25 of 1,582 recruiting studies, sorted by proximity — each links to its official registry page
Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/Lymphoma
NK-Cell Lymphoma, NK-Cell Leukemia
EARLY/Phase 1
Interventional 40 participants sought
Children's Hospital Orange County — Orange, California (17.3 mi)
· Sponsor: New York Medical College
Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A
Von Willebrand Disease, Type 3, Concomitant VWD and Hemophilia
Phase 1
Interventional 40 participants sought
The Center for Comprehensive Care and Diagnosis of Inherited Blood Disorders (CIBD) — Orange, California (17.3 mi)
· Sponsor: Bleeding and Clotting Disorders Institute Peoria, Illinois
AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Multiple Myeloma
Multiple Myeloma
Phase 1, Phase 2
Interventional 226 participants sought
Research Site — Irvine, California (19.9 mi)
· Sponsor: AstraZeneca
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Children's Hospital of Orange County — Orange, California (17.3 mi)
· Sponsor: National Cancer Institute (NCI)
Wearable Device and Behavioral Support for Enhancing Arm Use After Stroke
Chronic Stroke Patients
N/A
Interventional 32 participants sought
University of California Irvine — Irvine, California (19.9 mi)
· Sponsor: University of California, Irvine
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
N/A
Interventional 400 participants sought
Loma Linda University Medical Center — Loma Linda, California (21.7 mi)
· Sponsor: Medtronic MiniMed, Inc.
A Study of Zasocitinib in Adults With Hidradenitis Suppurativa
Hidradenitis Suppurativa
Phase 2
Interventional 90 participants sought
First OC Dermatology Research — Fountain Valley, California (24.7 mi)
· Sponsor: Takeda
A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated
Diabetic Macular Edema
Phase 1, Phase 2
Interventional 49 participants sought
Retina Associates of Southern California — Huntington Beach, California (28.6 mi)
· Sponsor: Boehringer Ingelheim
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
Neovascular Age-related Macular Degeneration
Phase 4
Interventional 188 participants sought
Orange County Retina Med Group — Santa Ana, California (19.2 mi)
· Sponsor: Genentech, Inc.
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma
Phase 1
Interventional 694 participants sought
City of Hope - Orange County Lennar Foundation Cancer Center /ID# 278589 — Irvine, California (19.9 mi)
· Sponsor: AbbVie
A Study to Evaluate the Safety of AB-1003 (Previously LION-101) in Subjects With Genetic Confirmation of LGMD2I/R9 (Part1)
Limb Girdle Muscular Dystrophy, Limb-Girdle Muscular Dystrophy Type 2
Phase 1, Phase 2
Interventional 10 participants sought
University of California - Irvine — Irvine, California (19.9 mi)
· Sponsor: AskBio Inc
Study of Inebilizumab in Pediatric Subjects With Neuromyelitis Optica Spectrum Disorder
Neuromyelitis Optica Spectrum Disorder
Phase 2
Interventional 15 participants sought
Loma Linda University Children's Hospital - PIN — Loma Linda, California (21.7 mi)
· Sponsor: Amgen
Autologous Activated Adipose-derived Stem Cells (RB-ADSC) Injected Directly Into the Brain for Mild to Moderate Alzheimer's Disease
Alzheimer Disease
Phase 1
Interventional 18 participants sought
Hoag Memorial Hospital Presbyterian — Newport Beach, California (26.8 mi)
· Sponsor: Regeneration Biomedical, Inc.
Shorter Versus Extended Course of Antibiotic Therapy for Necrotizing Soft Tissue Infections
Necrotizing Soft Tissue Infection
N/A
Observational 50 participants sought
University of California Irvine Medical Center — Orange, California (17.3 mi)
· Sponsor: University of California, Irvine
Phytocannabinoids for Reducing Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer Survivors
Breast Carcinoma, Chemotherapy-Induced Peripheral Neuropathy
Phase 2
Interventional 120 participants sought
City of Hope at Irvine Lennar — Irvine, California (19.9 mi)
· Sponsor: City of Hope Medical Center
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Endometrial Cancer
Phase 3
Interventional 600 participants sought
Research Site — Irvine, California (19.9 mi)
· Sponsor: AstraZeneca
Evaluation of IV AMBTX-01 (Neridronate) for Treatment of CRPS Type 1 (CRPS-RISE)
Complex Regional Pain Syndrome Type I
Phase 3
Interventional 270 participants sought
Ambros Clinical Trial Site — Tustin, California (17.0 mi)
· Sponsor: Ambros Therapeutics, Inc.
Phase 2 Study to Evaluate EI-001 in Non-segmental Vitiligo Patients
Non-segmental Vitiligo
Phase 2
Interventional 45 participants sought
Marvel Clinical Research — Huntington Beach, California (28.6 mi)
· Sponsor: Elixiron Immunotherapeutics (Hong Kong) Ltd.
PyL in Patients With High Risk and Biochemically Recurrent Prostate Cancer
Prostate Cancer
Phase 2
Interventional 184 participants sought
Hoag Memorial Hospital Presbyterian — Irvine, California (19.9 mi)
· Sponsor: Hoag Memorial Hospital Presbyterian
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Bladder Carcinoma, Ureter Carcinoma
N/A
Observational 2,020 participants sought
Hoag Memorial Hospital Presbyterian — Newport Beach, California (26.8 mi)
· Sponsor: Guardant Health, Inc.
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
Systemic Sclerosis Associated Interstitial Lung Disease, Scleroderma, Systemic
Phase 2, Phase 3
Interventional 300 participants sought
GSK Investigational Site — Upland, California (17.0 mi)
· Sponsor: GlaxoSmithKline
Telemedicine for Improvement of Care for Older Adults With Cancer in the Underserved Community, The GAIN-S Trial
Hematopoietic and Lymphoid System Neoplasm, Malignant Solid Neoplasm
N/A
Interventional 216 participants sought
City of Hope Upland — Upland, California (17.0 mi)
· Sponsor: City of Hope Medical Center
A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia
Hyperphosphatemia, Chronic Kidney Disease Requiring Chronic Dialysis
Phase 2
Interventional 168 participants sought
North America Research Institute — San Dimas, California (21.9 mi)
· Sponsor: R1 Therapeutics
TTVR STRONG Under Coverage With Evidence Development (CED) Study
Tricuspid Regurgitation
N/A
Observational 2,044 participants sought
Edwards Lifesciences — Irvine, California (19.9 mi)
· Sponsor: Edwards Lifesciences
ATLAS-1: Advanced Trial for Longitudinal Assessment in Salma 1
Depressed Mood
N/A
Observational 5,000 participants sought
Salma Health — Laguna Hills, California (19.2 mi)
· Sponsor: Salma Health, Inc.